Search

Your search keyword '"Agol VI"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Agol VI" Remove constraint Author: "Agol VI"
225 results on '"Agol VI"'

Search Results

1. Existence and significance of viral nonreplicative RNA recombination.

2. Non-Canonical Translation Initiation Mechanisms Employed by Eukaryotic Viral mRNAs.

3. The Baltimore Classification of Viruses 50 Years Later: How Does It Stand in the Light of Virus Evolution?

4. Polio eradication at the crossroads.

5. In pursuit of intriguing puzzles.

6. Characterization of Mutational Tolerance of a Viral RNA-Protein Interaction.

7. Emergency Services of Viral RNAs: Repair and Remodeling.

8. Pressure for Pattern-Specific Intertypic Recombination between Sabin Polioviruses: Evolutionary Implications.

9. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.

10. Mutational robustness and resilience of a replicative cis-element of RNA virus: Promiscuity, limitations, relevance.

11. The 2010 outbreak of poliomyelitis in Tajikistan: epidemiology and lessons learnt.

12. Cytopathic effects: virus-modulated manifestations of innate immunity?

13. Suppression of injuries caused by a lytic RNA virus (mengovirus) and their uncoupling from viral reproduction by mutual cell/virus disarmament.

14. Viral security proteins: counteracting host defences.

15. Theiler's murine encephalomyelitis virus L* amino acid position 93 is important for virus persistence and virus-induced demyelination.

16. Interactions between viral and prokaryotic pathogens in a mixed infection with cardiovirus and mycoplasma.

17. Antiapoptotic activity of the cardiovirus leader protein, a viral "security" protein.

18. Mengovirus-induced rearrangement of the nuclear pore complex: hijacking cellular phosphorylation machinery.

19. Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance.

20. Immunisation against poliomyelitis: moving forward.

21. Vaccination against polio should not be stopped.

22. Significance of the C-terminal amino acid residue in mengovirus RNA-dependent RNA polymerase.

23. A GCUA tetranucleotide loop found in the poliovirus oriL by in vivo SELEX (un)expectedly forms a YNMG-like structure: Extending the YNMG family with GYYA.

24. Vaccine-derived polioviruses.

25. Polyadenylation of genomic RNA and initiation of antigenomic RNA in a positive-strand RNA virus are controlled by the same cis-element.

26. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties.

27. Nucleocytoplasmic traffic disorder induced by cardioviruses.

28. Molecular mechanisms of poliovirus variation and evolution.

29. [How the poliovirus changes a cell].

30. [Variable mechanisms of RNA-recombination].

31. Don't drop current vaccine until we have new ones.

32. Variability in apoptotic response to poliovirus infection.

33. Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine.

34. Diverse Mechanisms of RNA Recombination.

35. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores.

36. Circulating vaccine-derived polioviruses: current state of knowledge.

37. Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future.

38. Nonreplicative homologous RNA recombination: promiscuous joining of RNA pieces?

39. Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses.

40. Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha.

41. The major apoptotic pathway activated and suppressed by poliovirus.

42. Unstable receptors disappear from cell surface during poliovirus infection.

43. [Viral infectious and cell differentiation].

44. Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.

45. [Genomic instability in picornaviruses].

46. Cell-specific proteins regulate viral RNA translation and virus-induced disease.

47. New ways of initiating translation in eukaryotes.

48. Poliovirus protein 3A inhibits tumor necrosis factor (TNF)-induced apoptosis by eliminating the TNF receptor from the cell surface.

49. [Translational control of the picornavirus phenotype].

50. Molecular mechanisms of translation initiation in eukaryotes.

Catalog

Books, media, physical & digital resources